Yarranton Geoffrey Thomas 4
4 · KALOBIOS PHARMACEUTICALS INC · Filed May 2, 2013
Insider Transaction Report
Form 4
Yarranton Geoffrey Thomas
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2013-04-30+75,000→ 75,000 totalExercise: $6.00Exp: 2023-04-30→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The option shares will vest and become exercisable ratably over 36 months of continuous service after May 1, 2013.